首页 | 本学科首页   官方微博 | 高级检索  
     


UCH‐L1 expression of podocytes in diseased glomeruli and in vitro
Authors:Yuan Liu  Jiajing Wu  Huijuan Wu  Tianzhan Wang  Hualei Gan  Xin Zhang  Ye Liu  Ruixi Li  Zhonghua Zhao  Qi Chen  Muyi Guo  Zhigang Zhang
Affiliation:1. Department of Pathology and Key Laboratory of Molecular Medicine (Ministry of Education), Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China;2. Department of Pathology, Putuo Hospital, Shanghai University of Chinese Traditional Medicine, Shanghai 200062, People's Republic of China;3. Department of Anatomy, Histology and Embryology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China
Abstract:Ubiquitin C‐terminal hydrolase‐L1 (UCH‐L1), an important member of de‐ubiquitination enzyme families involved in the ubiquitin–proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH‐L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH‐L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH‐L1 and the regulation of this expression in podocytes. The results demonstrated that UCH‐L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH‐L1 expression significantly increased in the two groups of podocytes co‐cultured with mesangial cells exposed to ATS 50 µl/ml and ATS 50 µl/ml with normal human serum 30 µl/ml, respectively (p < 0.05), while the other groups treated with TGFβ1 1 ng/ml, TNFα 10 ng/ml or IL‐1 10 ng/ml had little rise of UCH‐L1 expression, with no statistical significance compared with normal control (p > 0.05). Further tests indicated that the percentage of PCNA‐positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH‐L1 and that its expression can be increased in these immunocomplex‐mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH‐L1. The expression of UCH‐L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex‐mediated injury. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords:ubiquitin C‐terminal hydrolase‐L1 (UCH‐L1)  podocyte  glomerulonephritis  immunocomplex
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号